-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-28
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody is a Cy3-conjugated secondary antibody for detecting goat IgG in ICC/IF, frozen and paraffin IHC, flow cytometry, and fluorescence-based ELISA. It should be paired with goat-derived IgG primary antibodies and is not a general secondary reagent for non-goat primaries or nonfluorescent detection formats.
-
Cepharanthine: Translational Assay Workflows
2026-08-28
Cepharanthine connects conventional cell assays with patient-derived endometrial organoids and an in vivo lesion model, giving researchers a practical route from phenotype to mechanism. This workflow highlights DNA damage, G0/G1 arrest, and mitochondrial apoptosis while separating promising preclinical signals from clinical claims.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-08-28
The reference study identifies CD44-mediated metabolic rewiring as a selective dependency of IDH-mutant leukemia, linking cell-adhesion signaling to NADPH production and R-2HG biosynthesis. Its isogenic CRISPR-based design provides a useful framework for separating IDH-driven biology from co-occurring lesions and for testing combination strategies that pair IDH inhibition with CD44-directed interventions.
-
Gemini Quaternary Ammonium Compounds for Biocidal Control
2026-08-27
The reference study synthesized 16 novel octenidine-derived gemini quaternary ammonium compounds and evaluated their antibacterial, antibiofilm, antifungal, virucidal, and cytotoxicity profiles. Compounds 6–8 and especially compound 12 showed useful combinations of activity and tolerability, while compound 1 displayed unusually selective antifungal activity, providing a structure–activity framework for next-generation antiseptic research.
-
Rottlerin: From PKCδ Mechanism to Translation
2026-08-26
Rottlerin offers translational researchers a way to interrogate PKCδ-linked control of proliferation, apoptosis, cytoskeletal organization, and pathogen entry. This thought-leadership article connects oncology evidence with mechanistic findings from Spiroplasma infection research while emphasizing selectivity, assay design, endothelial safety, and the limits of preclinical interpretation.
-
SW033291: From Target Engagement to Tissue Repair
2026-08-26
SW033291 is a nanomolar 15-PGDH inhibitor for connecting prostaglandin E2 elevation with hematopoiesis stimulation and tissue regeneration research. This article presents an assay-centered framework for distinguishing direct target engagement from downstream repair phenotypes, informed by recent muscle-regeneration findings.
-
Filipin III for Membrane Cholesterol Detection
2026-08-26
Learn how Filipin III, SKU B6034, can support orthogonal cholesterol detection in membranes when viability or cytotoxicity results are difficult to interpret. This scenario-based guide covers assay compatibility, solution handling, fluorescence limitations, immunometabolic context, and practical vendor-selection criteria.
-
Hexetidine Workflow for Oral Antimicrobial Assays
2026-08-25
Hexetidine, also known as NSC-17764, supports practical planktonic, biofilm, and oral-rinse simulation studies against bacteria and Candida albicans. This guide translates comparative mouthrinse research into reproducible workflows, concentration choices, and troubleshooting strategies for dental plaque reduction and gingivitis treatment research.
-
Grx2, HNRNPA2B1, and Ferroptosis in Diabetic Cataract
2026-08-24
The reference study identifies a redox-regulatory mechanism in diabetes-mediated cataractogenesis: glutaredoxin 2 protects lens epithelial cells by limiting HNRNPA2B1 S-glutathionylation, thereby preserving PTEN/AKT signaling and reducing ferroptotic injury. Its combined use of LC-MS/MS, co-immunoprecipitation, redox measurements, and functional perturbation provides a framework for connecting protein modification to lens-cell death.
-
Beclin1, Ferroptosis, and Doxorubicin Liver Injury
2026-08-24
A recent study identifies Beclin1 as a regulator that links excessive autophagy with ferroptotic liver injury during doxorubicin exposure. Beclin1 knockdown and DHODH overexpression reduced oxidative stress, lipid peroxidation, and tissue damage, positioning the Beclin1–DHODH relationship as a mechanistic focus for hepatotoxicity research.
-
SM-102: From Lipid Design to Assay Decisions
2026-08-23
SM-102 is an ionizable lipid used to build lipid nanoparticle mRNA delivery systems. This evidence-led guide connects its molecular role and handling requirements with machine-learning results, helping researchers design more interpretable formulation and assay workflows.
-
Intestinal TM6SF2 and the Gut–Liver Axis in MASH
2026-08-22
A 2025 Nature Metabolism study shows that intestinal TM6SF2 deficiency can drive MASH by disrupting epithelial barrier function, reshaping the microbiota and increasing gut-derived lysophosphatidic acid signaling to the liver. The work moves TM6SF2 biology beyond hepatocyte lipid handling and identifies microbiota modulation and LPA-receptor blockade as experimentally testable intervention points.
-
From Sulfonamide SAR to Smarter Delivery
2026-08-21
A translational framework for connecting sulfonamide optimization, CYP 2C9 risk reduction, and DMG-PEG2000-NH2-enabled lipid delivery research without overstating the current evidence.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Workflow
2026-08-20
ARCA Cy3 EGFP mRNA (5-moUTP) combines direct Cy3 tracking with functional EGFP reporter expression in one transcript. This dual-readout design helps researchers separate cellular uptake, intracellular localization, endosomal escape, and translation during mRNA transfection in mammalian cells.
-
11β-HSD1, Notch, and NK Cells in Liver Fibrosis
2026-08-20
A 2025 mouse study identifies a dual immunometabolic mechanism by which 11β-HSD1 inhibition reduces liver fibrosis: suppression of Notch signaling and enhancement of natural killer cell-mediated clearance of activated hepatic stellate cells. Its integrated use of biochemical, transcriptomic, and mass-cytometry readouts provides a useful framework for interpreting fibrosis mechanisms, while the TAA model requires careful consideration before translation to MASLD or MASH.